eLearning module: Improving confidence by explaining key terminology
In this expert authored eLearning module, Professor Huub Schellekens explains the key terminology commonly used when discussing biosimilars, with the aim to improve its understanding and confidence in clinical practice.
This module will take up to 20 minutes to complete.
On completion of the eLearning module, you will be able to:
- Explain key terminology associated with biosimilars such as: extrapolation, interchangeability, pharmacovigilance, and traceability/labeling.
- Pass on your newly acquired knowledge of these concepts to educate other HCPs and improve confidence in biosimilars.
All medical oncologists, specialist nurses, and allied healthcare professionals working with patients for whom biosimilars may represent a treatment option.